Skip to main content
Hilario Yankey, MD, Radiation Oncology, Philadelphia, PA

HilarioNwiakojoYankeyMDMBA

Radiation Oncology Philadelphia, PA

Attending Physician at Fox Chase Cancer Center Radiation Oncology Department

Dr. Yankey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Yankey's full profile

Already have an account?

  • Office

    333 Cottman Ave
    Philadelphia, PA 19111
    Phone+1 774-823-9763

Education & Training

  • Temple University Hospital/Fox Chase Cancer Center
    Temple University Hospital/Fox Chase Cancer CenterResidency, Radiation Oncology, 2020 - 2024
  • Crozer-Chester Medical Center
    Crozer-Chester Medical CenterInternship, Transitional Year, 2019 - 2020
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 2019, MD
  • Drexel University
    Drexel University BS, Cell/Molecular Biology & Genetics, Magna Cum Laude, 2011 - 2014
  • University of Ghana School of Pharmacy
    University of Ghana School of PharmacyBS, 2010 - 2011

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2019 - 2024

Awards, Honors, & Recognition

  • Excellence in Research Award Crozer Chester Medical Center, 2020
  • TUSM Academic Achievement Award Temple University School of Medicine, 2015-2019

Publications & Presentations

PubMed

Journal Articles

  • Survival and Toxicity in Patients with Unresectable or Inoperable Biliary Tract Cancers with Ablative Radiotherapy versus Non-Ablative Chemoradiation  
    Hilario Yankey; Karen J. Ruth; Efrat Dotan; Sanjay Reddy; Joshua E. Meyer, Advances in Radiation Oncology, 12/1/2023
  • Absence of fibrosis after Stereotactic Body Radiation Therapy (SBRT) for hepatocellular carcinoma (HCC) in a multiple-transplant patient  
    Yankey H, Meyer JE, Anaokar J, Applied Radiation Oncology, 12/20/2018

Books/Book Chapters

Abstracts/Posters

  • Survival and toxicity in patients with unresectable/inoperable biliary cancers treated with SBRT versus conventionally fractionated chemoradiation
    Hilario N. Yankey, Karen J. Ruth, Efrat Dotan, Sanjay Reddy, Tim Dougherty, Aneesh Pirlamarla and Joshua E. Meyer, ASTRO 2021, Chicago, IL, USA
  • Long Term Outcomes of Stereotactic Radiosurgery for Brain Metastases from Lung Cancer in the era of immunotherapy
    Yankey, H., Cantalino, J., Lanciano, R., Feng, J., Arrigo, S., Lamond, John., Hanlon, A, L., Lozano, A., Yang, J., Giesa, C., Crozer Keystone Health System Residency Research Day, Upland, PA, 5/27/2020
  • Completion Rate And Toxicity Of Hypo-Fractionated Radiotherapy For Retroperitoneal And Pelvic Soft Tissue Sarcomas
    Yankey, H., Hollawell, C., Ross, E., Farma, J. M., Esnaola, N., Meyer, J., von Mehren, M., Reddy, S., Abraham, J., Movva, S., Howell, K. J., Connective Tissue Oncology Society, Rome, Italy, 11/2018

Professional Memberships